Sandra G. Stoneman Esq. Net Worth

Ms. Sandra G. Stoneman Esq. biography

Sandra G. Stoneman Esq. is the Chief Legal Officer, Gen. Counsel & Corp. Sec. at Immunome.

What is the salary of Ms Esq?

As the Chief Legal Officer and Gen. Counsel & Corp. Sec. of Immunome, the total compensation of Ms Esq at Immunome is $443,432. There are 1 executives at Immunome getting paid more, with Dr. Purnanand Duddu Sarma having the highest compensation of $657,442.

How old is Ms Esq?

Ms Esq is 48, she's been the Chief Legal Officer and Gen. Counsel & Corp. Sec. of Immunome since . There are 3 older and no younger executives at Immunome. The oldest executive at Immunome, Inc. is Dr. Dennis H. Giesing, 69, who is the Chief Devel. Officer.

What's Ms Esq's mailing address?

Sandra's mailing address filed with the SEC is C/O IMMUNOME, INC., 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011.

Insiders trading at Immunome

Over the last 4 years, insiders at Immunome have traded over $0 worth of Immunome stock and bought 480,004 units worth $5,722,735 . The most active insiders traders include Clay B Siegall, Jean Jacques Bienaime, and Michael Rapp. On average, Immunome executives and independent directors trade stock every 84 days with the average trade being worth of $518,362. The most recent stock trade was executed by Jean Jacques Bienaime on 15 August 2024, trading 7,000 units of IMNM stock currently worth $97,580.

What does Immunome do?

Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.

Immunome executives and stock owners

Immunome executives and other stock owners filed with the SEC include:

• Dr. Purnanand Duddu Sarma,
  Pres, CEO & Director
• Sandra G. Stoneman Esq.,
  Chief Legal Officer, Gen. Counsel & Corp. Sec.
• Dr. Michael J. Morin Ph.D.,
  Chief Scientist
• Dr. Scott K. Dessain M.D., Ph.D.,
  Co-founder & Chairman of the Scientific Advisory Board
• Dr. Dennis H. Giesing,
  Chief Devel. Officer
• Matthew K. Robinson Ph.D.,
  Sr. VP of R&D
• Corleen M. Roche,
  Chief Financial Officer
• Michael Widlitz,
  Director
• Michael Lefenfeld,
  Director
• Dennis H Giesing,
  Chief Development Officer
• Jean Jacques Bienaime,
  
• Max Rosett,
  EVP, Operations & CFO
• James P Boylan,
  
• Philip Tsai,
  Chief Technology Officer
• Franklyn G Prendergast,
  Director
• Sandra M Swain,
  
• I Wistar Iii Morris,
  10% owner
• Richard F Fitzgerald,
  Chief Financial Officer
• John L Lamattina,
  Director
• Michael Rapp,
  Director
• Corleen M. Roche,
  Chief Financial Officer
• Philip Wagenheim,
  
• Richard A Baron,
  Director
• Matthew K Robinson,
  Chief Technology Officer
• Purnanand D Sarma,
  President and CEO
• Clay B Siegall,
  President and CEO
• Isaac Barchas,
  
• Phil Noland Roberts,
  Chief Technology Officer
• Carol Schafer,
  
• Kinney Horn,
  CHIEF BUSINESS OFFICER
• Jack Higgins,
  Chief Scientific Officer
• Robert Lechleider,
  Chief Medical Officer
• Bruce Turner,
  Chief Strategy Officer